Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Bioceres Crop Solutions Corp is an agricultural inputs business based in the US. Bioceres Crop Solutions shares (BIOX) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $13.32 |
|---|---|
| 52-week range | $10.21 - $16.43 |
| 50-day moving average | $13.35 |
| 200-day moving average | $13.41 |
| Wall St. target price | $22.12 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.04 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.32 from 2022-06-28
| 1 week (2022-06-22) | 9.36% |
|---|---|
| 1 month (2022-05-27) | -7.76% |
| 3 months (2022-03-30) | 2.30% |
| 6 months (2021-12-30) | -3.13% |
| 1 year (2021-06-30) | -5.20% |
|---|---|
| 2 years (2020-06-30) | 119.80% |
| 3 years (2019-06-28) | 151.32% |
| 5 years (2017-06-26) | N/A |
Valuing Bioceres Crop Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bioceres Crop Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bioceres Crop Solutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50 million.
The EBITDA is a measure of a Bioceres Crop Solutions's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $308 million |
|---|---|
| Operating margin TTM | 14.01% |
| Gross profit TTM | $90.3 million |
| Return on assets TTM | 6.24% |
| Return on equity TTM | 2.05% |
| Profit margin | -0.5% |
| Book value | $2.14 |
| Market capitalisation | $594.5 million |
TTM: trailing 12 months
We're not expecting Bioceres Crop Solutions to pay a dividend over the next 12 months.
Over the last 12 months, Bioceres Crop Solutions's shares have ranged in value from as little as $10.21 up to $16.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bioceres Crop Solutions's is 0.7204. This would suggest that Bioceres Crop Solutions's shares are less volatile than average (for this exchange).
Bioceres Crop Solutions Corp. , together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.